drugset / Trial / NCT04507711

Palonosetron and Blood Coagulation

NCT04507711

Non-randomizedSingle-groupOpen-labelBasic science

Summary

Palonosetron may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of palonosetron. The investigators therefore will perform the present study to measure the effect of palonosetron levels using thromboelastography.

Timeline

Start
2020-09-16
Primary completion
2023-11-15
Completion
2023-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Palonosetron Other / unclassified 0 ml
Subject Palonosetron Other / unclassified 0.001 ml
Subject Palonosetron Other / unclassified 0.01 ml
Subject Palonosetron Other / unclassified 0.1 ml